Company Enzon Pharmaceuticals Inc Nasdaq
Equities
US2939041081
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 80 | 13/13/13 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Randolph Read
CHM | Chairman | 71 | 04/20/04 |
Director/Board Member | 67 | 01/22/01 | |
Jordan Bleznick
BRD | Director/Board Member | 68 | 04/20/04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 74,214,603 | 66,170,649 ( 89.16 %) | 0 | 89.16 % |
Company contact information
Enzon Pharmaceuticals, Inc.
20 Commerce Drive Suite 135
07016, Cranford
+732 980 4500
http://www.enzon.comSector
1st Jan change | Capi. | |
---|---|---|
+7.52% | 113B | |
+11.38% | 106B | |
+0.73% | 22.27B | |
-12.64% | 22.22B | |
-4.41% | 19.43B | |
-37.85% | 17.87B | |
-8.58% | 17.24B | |
+7.77% | 14.29B | |
+37.41% | 12.52B |
- Stock Market
- Equities
- ENZN Stock
- Stock
- Company Enzon Pharmaceuticals Inc